The Chilled Future Of RNA Therapeutics Filling & Freezing Applications

With continuously advancing novel treatments pushing the limits of biotechnology, biotech and biopharma companies need to consider a change from their traditional and rigid manufacturing processes. Solution providers are driving process optimization in order to increase efficiency and meet the needs of these new therapies, however different product characteristics come with different challenges and risks for fluid management. Modular and flexible technologies can help to overcome these challenges and improve product quality. Now technological advancements, such as plate-based freezing and thawing and automated aseptic filling, are playing a major role in process optimization with regards to cost-efficiency, reduction of product loss, and advanced documentation according to current Good Automated Manufacturing Practices (GAMP) while still maintaining the highest possible product quality of RNA therapeutics.

Fueled by the developments of single-use technologies, Single Use Support strives to pave the way for innovation in the biopharmaceutical industry.